Intellectual Ventures founder and CEO Nathan Myhrvold illuminates why people and the planet need every source of reliable, carbon-free energy we can get.
Read MoreInsights
Intellectual Ventures founder and CEO Nathan Myhrvold illuminates why people and the planet need every source of reliable, carbon-free energy we can get.
Read MoreInsights
A new study by Global Good and its partners explores how reinventing two common household items—the window and door—could save lives by keeping pesky mosquitoes out of African homes.
Read MoreInsights
In a new study published in the journal Icarus, Nathan argues that astronomers don’t have as good a handle on the size and other physical characteristics of asteroids as they previously thought.
Read MoreInsights
The World Health Organization-approved eLearning tool can be used regardless of Internet access.
Read MorePress Releases
Microbiologists now have ability to adequately conduct microbiological tests in laboratories with unreliable access to power.
Read MorePress Releases
$1 million invested in Institute for the Global Entrepreneur at UC San Diego.
Read MorePress Releases
Dominion Harbor and IV to work together to provide greater access to IV portfolio.
Read MorePress Releases
As a result of the agreement with IV, Huawei has license to patents related to mobile devices.
Read MorePublications
With partners, Global Good is redesigning the window and door to keep deadly mosquitoes out of African homes.
Read MorePublications
Autoscope was tested in the Iquitos region of Peru in 2016 at two peripheral health facilities, with routine microscopy and PCR as reference standards. The main outcome measures include sensitivity and specificity of diagnosis of malaria from Giemsa-stained blood films, using PCR as reference.
Read MorePublications
Microbiological culture remains the most sensitive method for detecting viable and infectious bacteria, but these methods often require at least 24 hours to visibly identify bacterial growth.
Read MorePublications
Here, we review the principles underpinning lateral flow assays and the historical evolution of theory to predict their performance.
Read MoreMedia Coverage
The Seattle Times
IV research scientist Corrie Ortega shares her background and what her experience at IV has been like in this Seattle Times Q&A.
Read MoreMedia Coverage
Forbes
CEO of IV spinout Evolv recently joined the DealMakers Podcast to discuss his background and provide some insights for aspiring entrepreneurs.
Read MoreMedia Coverage
Axios
IV spinout TerraPower continues to develop innovative nuclear energy technology, making it safer, more efficient, and cheaper.
Read MoreMedia Coverage
CBS Sunday Morning
Our founder and CEO Nathan Myhrvold shares his experience with high speed food photography and other culinary pursuits with David Pogue.
Read More